Opticom expanded our network and provided strategic insights
Mavatar is at the forefront of precision medicine, leveraging over 20 years of research to push the boundaries of personalized healthcare. By incorporating AI and big data into their approach, Mavatar is working to revolutionize how diseases are understood and treated. To support their innovative mission, Mavatar partnered with Opticom to gain valuable insights and expand their network within the healthcare industry.
The CEO of Mavatar, Johan Juhlin, describes the significance of the partnership with Opticom and how it has influenced their strategic direction.
"Opticom has been incredibly helpful, with fantastic people who have expanded our network and provided us with strategic insights."
Reflecting on the future of precision medicine and how Mavatar is addressing key challenges, Johan says:
"The biggest challenge is that the healthcare system is not fully prepared for the big data we work with. There are many ethical considerations, particularly regarding the use of individual data like DNA. Mavatar is building a strong foundation to overcome these hurdles."
Looking ahead, Mavatar sees great potential in precision medicine and their role in shaping the future of healthcare:
"50% of patients are not receiving the right drug treatments. By ensuring each patient gets the right drug from the beginning, we can reduce costs and alleviate patient suffering."
Mavatar also emphasizes the ongoing potential for growth through their partnership with Opticom:
"We are excited about many future projects. Whether it is through meetings or commercial materialÂ
development, our partnership with Opticom will help us connect with the right stakeholders."
When asked to summarize the value of working with Opticom, Johan concluded:
"Opticom are knowledgeable, easy to work with, and have made a significant impact on our strategic planning."
Are you and your company also interested in working with us? Please connect here https://www.opticom.se/contact